GUANGZHOU: Zhong Nanshan (pic), a noted expert on respiratory illness, said his team is now actively developing antibodies to Covid-19, aiming to explore effective treatment methods more suitable for children under five years old in the following months.
"Now the research of Covid-19 drug in this group of people is not sufficient, and it lacks sufficient safety evidence," said Zhong, an academician of the Chinese Academy of Engineering.
